Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

CKD Venture Capital

Profile and portfolio

Parent Chong Kun DangHQ Seoul, South KoreaFounded 1997

CKD Venture Capital is the corporate venture arm of Chong Kun Dang, a pharmaceutical and biotech company. It was founded in 1997 and is based in Seoul, South Korea. It invests from seed to Series A. Sectors it names: biotech and life sciences, healthcare and digital health, artificial intelligence.

Every figure links to its source

Snapshot

Investment stage: Seed to Series A
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Series A
SectorsBiotech and life sciences, Healthcare and digital health, Artificial intelligence
GeographyAsia
OfficesSeoul, South Korea

Sources: S2 Dailymedi: CKD Venture Capital invests in antibody, cancer vaccine and raw material companies; S1 CKD Venture Capital: home page.

Graphic 1 of 1

Investment stage: Seed to Series A

Sources: S2 Dailymedi: CKD Venture Capital invests in antibody, cancer vaccine and raw material companies; S1 CKD Venture Capital: home page.

Download:Report a correction

Where it invests

Geography

Headquarters
Seoul, South Korea

Investment regionsS2S1

Key facts

FactValueStatusSource
Parent companyChong Kun DangSingle sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
Founded1997Single sourceS1
HeadquartersSeoul, South KoreaSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent and outside investorsSingle sourceS4
StagesSeed, Series A (inferred from announced rounds)EstimateS2

Fund vehicles

VehicleSizeYearSource
Smart CKD Bio-Healthcare No.1KRW 52bnS2
Startup Korea with CKD 2025KRW 20bn2025S2
K-Bio Medytox-CKD Vaccine FundKRW 50bn2026S2

Portfolio

Public sources name 4 portfolio companies.S3

Shared portfolio with other corporate VCs

1 companies on the CKD Venture Capital portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
Loftyrock Investment1Fin Therapeutics

Companies backed by the most corporate VCs

Every company on the CKD Venture Capital list

4 companies, as named in the sources cited.S3 Read the firm's list.

  • Altogen
  • Aston Science
  • Fin Therapeutics
  • Immunapps

Official pages

Read the firm's own pages for current information.

Sources

  1. S1CKD Venture Capital: home pageFirm
  2. S2Dailymedi: CKD Venture Capital invests in antibody, cancer vaccine and raw material companiesPress
  3. S3Dailymedi: CKD Venture Capital invests in targeted protein degradation developer Fin TherapeuticsPress
  4. S4HitNews: pharma industry prepares seed investment in bio ventures (2023-03-13)Press

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by CKD Venture Capital or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.